TOPIC 323 PHASE I; DEVELOPMENT OF RADIATION MODULATORS FOR USE DURING RADIOTHERAP

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$250,000.00
Award Year:
2013
Program:
SBIR
Phase:
Phase I
Contract:
N43CA130018
Agency Tracking Number:
N43CA130018
Solicitation Year:
2013
Solicitation Topic Code:
NCI
Solicitation Number:
n/a
Small Business Information
TERAPIO
11412 Bee Cave Rd, Suite 100, AUSTIN, TX, 78738-
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
806143207
Principal Investigator:
CHARLES CUNNINGHAM
(512) 697-8179
CCUNNINGHAM@TERAPIO.COM
Business Contact:
CHARLES CUNNINGHAM
(512) 697-8179
CCUNNINGHAM@TERAPIO.COM
Research Institution:
Stub




Abstract
Oral mucositis (OM) is a common side effect in oncology patients receiving radiation treatment. Mucosal breakdown causes pain which leads to increased use of narcotic analgesics and restriction of food intake. OM often progresses to septicemia, increasinghospital stays and costs, and ultimately discontinuation of radiotherapy. This impacts overall effectiveness of cancer therapy so development of an agent for prevention and treatment of OM is clearly an unmet need. Terapio is developing a drug, RLIP76-Proteoliposome (RLIP76-PL), as a radiation countermeasure. When administered systemically, RLIP76-PL dramatically improves survival in a mouse model of whole body radiation, leading to the hypothesis that it could be beneficial as a local application in treating specific radiation toxicities such as OM. This proposed research will test that hypothesis. In Specific Aim #1, the current formulation of RLIP76-PL will be modified to be used as a topical mouthwash. In Aim #2, the efficacy of the topical formulation of RLIP76-PL will be tested in a hamster model to evaluate its effectiveness in reducing the severity of OM after irradiation. Finally, in Specific Aim #3, systemic absorption of mucosally-applied RLIP76-PL will be investigated to guide future studies in atumor model to establish that RLIP76-PL is not tumor-protective. PUBLIC HEALTH RELEVANCE

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government